Abstract:Background: Transmission-based precautions against varicella-zoster virus (VZV) in healthcare settings are determined by the extent of rash (localized vs disseminated) and the immune status of the host. At our facility, immunocompetent patients with localized disease are placed in standard precautions whereas patients with disseminated disease and/or immunocompromised status are placed in airborne and contact isolation. The use of molecular diagnostics has increased recently, and patients can have a PCR positive for VZV in cerebral spinal fluid (CSF) without evidence of pneumonia or disseminated rash. These patients are classified as disseminated disease, but it is unlikely that they are spreading VZV via respiratory aerosols in the absence of other symptoms. Infection prevention guidance is limited in this situation, and these patients may be in unneeded isolation, with the potential for adverse patient effects and overutilizing PPE resources. We have described the clinical characteristics of patients with a PCR positive for VZV in CSF, and we evaluated the risk for transmitting VZV via airborne aerosols. Methods: A retrospective, single-center chart review was performed on all patients admitted with a PCR positive for VZV in CSF between July 2017 and November 2021. Chart review was performed to gather data regarding clinical presentation, patient characteristics, and risk factors. Results: In total, 38 patients were identified who had a PCR positive for VZV in CSF; 22 (57.9%) were male and 16 (42.1%) were female. The median age was 47 years (IQR, 38–69). Also, 15 patients (39.5%) were immunocompromised. Moreover, 26 patients (68.4%) had a rash; 19 (50%) had localized rash; and 7 (18.4%) had disseminated rash involving ≥3 dermatomes. However, 12 patients (31.5%) had neither rash nor pneumonia. Furthermore, 5 patients (13.1%) had PCR positive for VZV in CSF and developed rash within the following 2–7 days (2 with disseminated rash). In addition, 6 patients (15.8%) had pneumonia. Of the 6 patients with pneumonia, 4 (10.5%) were immunocompromised and 3 (7.9%) were above 65-year-old. 32 patients (84.2%) were kept in airborne and contact precautions. 1 (2.6%) patient had a documented record of at least 1 dose of Shingrix vaccine. Conclusions: Most patients with a PCR test positive for VZV in the CSF were not immunocompromised and did not have evidence of disseminated rash or pneumonia. The risk of airborne transmission of VZV via small aerosols appears to be low in patients with a PCR test positive for VZV in the CSF without evidence of disseminated rash or pneumonia. Airborne isolation may not be required for many of these patients. Funding: None Disclosures: None

Clinical and radiological features of a cluster of immunocompetent adolescents with varicella pneumonia: a descriptive study

Prevalence and progression of pneumonia in immunocompetent adults with varicella

Viral etiology of life-threatening pediatric pneumonia: A matched case-control study

Differences In Clinical Features And Laboratory Results Between Adults And Children With Sars-Cov-2 Infection

Varicella Pneumonia in Immunocompetent Adults: Symptomatic and Asymptomatic Cases

Association between emphysema and other pulmonary computed tomography patterns in primary varicella pneumonia: A retrospective cohort study

Varicella pneumonia in a healthy 31-year-old female with no prior varicella immunity and no skin rush: A case report

Childhood COVID-19: a Multicentre Retrospective Study

[Effect of the varicella vaccination on the clinical characteristics of herpes zoster cases aged 20 years and under]

Epidemiological, Clinical Characteristics of Cases of SARS-CoV-2 Infection with Abnormal Imaging Findings

Clinical Features of Varicella in Children in 1980-1999

A Multicenter Study of Viral Aetiology of Community-Acquired Pneumonia in Hospitalized Children in Chinese Mainland

Clinical characteristics of Chinese children with EV‐D68‐associated pneumonia: A single‐center retrospective analysis

Clinical Course and Factors Associated with Viral RNA Shedding and Radiologic Resolution in Patients with COVID-19: a Retrospective Study

Zoster on the brain: Clinical characteristics of patients PCR positive for varicella-zoster virus in cerebrospinal fluid and implications for transmission base

Different Clinical Presentations and Outcomes of Disseminated Varicella in Children With Primary and Acquired Immunodeficiencies

The Epidemiologic and Clinical Features of Radiographic-Confirmed Community–Acquired Pneumonia Among Chinese Children: A Retrospective Hospital-Based Study

Clinical features of Chinese children with COVID‐19 and other viral respiratory infections

Disseminated Varicella-Zoster Virus Presenting With Pneumonitis and Diffuse Alveolar Hemorrhage in an Immunocompetent Patient

Clinical Features of Pediatric Patients with COVID-19: a Report of Two Family Cluster Cases

Clinical and imaging features of pediatric COVID-19